The Federal Trade Commission should allege specific regulatory violations if it warns consumer health product firms about unsubstantiated ad claims, not make general statements about its expectations in form letters to the companies, industry trade groups argue in a citizen petition.
Enforcing a notice of penalty offense (NPO) the FTC sent to nearly 700 consumer product firms in April “would violate...




